Epratuzumab

(Synonyms: Antibody hLL 2; AMG-412)
Kundenbewertung

Based on 1 Customer Validation

Epratuzumab (Antibody hLL 2) is an anti-CD22 IgG1 monoclonal antibody. Epratuzumab is also a tumor-imaging agent and an immunomodulatory agent. Epratuzumab can induce CD22 phosphorylation. Epratuzumab has been used to research non-Hodgkin’s lymphomas (NHL) and certain autoimmune diseases.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 99.53%
  • CAS. Nr.: 205923-57-5
  • Molecular Weight:146.58 kDa
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biologische Aktivität
  • Chemical Information
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00